References
- Gerstein DR, Harwood HJ. Treating Drug problems Volume 1: A study of effectiveness and financing of public and private drug treatment systems. Institute of Medicine, National Academy Press, Washington 1990
- Mattick RP, Hall W. Is detoxification effective?. Lancet 1996; 347: 97–100
- Judson BA, Goldstein A. Naltrexone treatment of heroin addiction: One-year follow-up. Drug Alcohol Depend 1984; 13: 357–365
- Osborn E, Grey C, Reznikoff M. Psychosocial adjustment, modality choice, and outcome in naltrexone versus methadone treatment. Am J Drug Alcohol Abuse 1986; 12: 383–388
- San, L, et al, Pomarol, G, Peri, JM. Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts. Br J Addiction 1991; 86: 983–990
- Miotto, K, et al, McCann, MJ, Rawson, RA. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug Alcohol Depend 1997; 45: 131–145
- Thomas, M, et al, Kauders, F, Harris, M. Clinical experiences with naltrexone in 370 detoxified addicts. Narcotic antagonists: Naltrexone, D Julius, Renault, P. National Institute on Drug Abuse, Rockville, MD 1976; 9: 88–92, In
- Washton AM, Pottash AC, Gold MS. Naltrexone in addicted business executives and physicians. J Clin psychiat 1984; 45: 4–6
- Mayor S. Specialists criticise treatment for heroin addiction. BMJ 1997; 314: 1365–1365
- English, D, et al, Holman, CJD, Milne, E. The quantification of drug caused morbidity and mortality in Australia 1995 edition. Common-wealth Department of Human Services and Health, Canberra 1995
- Gossop M, Strang J. Rapid anaesthetic-antagonist detoxification of heroin addicts: what origins, evidence base and clinical justification?. Br J Intensive Care March/April, 1997; 66–69
- Herman BH, Czechowicz D. NIDA Scientific Report of Ultra Rapid Detoxification with Anesthesia (UROD): Opinion of the Consultants and Criteria Relating to Evaluating the Safety and Efficacy of UROD. National Institute on Drug Abuse, Washington February, 1996, 23